Vertex And CRISPR Therapeutics: Historic Exa-cel Approval, Why Market Is Nonplussed (VRTX)


Investment Overview Historic Approval Validates CRISPR Gene Editing Approach

News broke this afternoon that the Food and Drug Agency (“FDA”) has granted approval to a CRISPR-based gene editing therapy for the first time in history. It is an historic